Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Life Foods, 52% Decrease in Ordinary Profit for The Current Fiscal Year, Resuming Dividends at 5 yen for the First Time in five terms., Plan to Continue the 5 yen Policy This Fiscal Year as Well
3065 Life Foods Co., Ltd. 【J-GAAP】
Earnings ReportLife Foods Co., Ltd. <3065> [TSE Std] announced its financial results in the afternoon session on April 14th (15:15). The ordinary profit (non-consolidated) for the fiscal year ending February 2025 expanded 83 times that of the previous period to 414 million yen. However, for the fiscal year ending February 2026 is also bleak, with an expected significant drop by 51.7% from the previous period to 200 million yen.
At the same time, the company increased the final dividend for the previous term from no dividends to 5 yen dividends were reinstated for the first time infive terms., and has decided to continue with a dividend of 5 yen for the current term as well.
In the most recent three-month period, from December to February (4Q), the ordinary profit/loss turned to a loss of 15 million yen (compared to a profit of 34 million yen in the same period last year). The operating profit/loss margin worsened from 1.2% in the same period last year to -0.9%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 9,888 | -593 | -204 | -447 | -146.2 | 0 | Apr 17, 2023 | J-GAAP |
Feb, 2024 | 10,426 | -25 | 5 | -734 | -239.8 | 0 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 9,783 | 347 | 414 | 402 | 130.7 | 5 | Apr 14, 2025 | J-GAAP |
YoY | -6.2% | - | +8,180.0% | - | - |
Full Year Results vs. Previous Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2025 Guidance | 9,602 | 217 | 282 | 145 | 47.0 | 0 | Jan 14, 2025 | J-GAAP |
Feb, 2025 Results | 9,783 | 347 | 414 | 402 | 130.7 | 5 | Apr 14, 2025 | J-GAAP |
Revision Rate | +1.9% | +59.9% | +46.8% | +177.2% | +177.8% |
Current Period Guidance
H1 Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Aug, 2024 | 4,936 | 260 | 308 | 218 | 71.0 | 0 | Oct 11, 2024 | J-GAAP |
Mar - Aug, 2025 Guidance | 4,842 | 142 | 160 | 113 | 36.6 | 0 | Apr 14, 2025 | J-GAAP |
YoY | -1.9% | -45.4% | -48.1% | -48.2% | -48.4% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2024 | 10,426 | -25 | 5 | -734 | -239.8 | 0 | Apr 15, 2024 | J-GAAP |
Feb, 2025 | 9,783 | 347 | 414 | 402 | 130.7 | 5 | Apr 14, 2025 | J-GAAP |
Feb, 2026 Guidance | 9,511 | 163 | 200 | 106 | 34.3 | 5 | Apr 14, 2025 | J-GAAP |
YoY | -2.8% | -53.0% | -51.7% | -73.6% | -73.7% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec - Feb, 2023 | 2,512 | 31 | 34 | -84 | -27.4 | 1.2 | Apr 15, 2024 | J-GAAP |
Mar - May, 2024 | 2,485 | 146 | 156 | 146 | 47.7 | 5.9 | Jul 11, 2024 | J-GAAP |
Jun - Aug, 2024 | 2,451 | 114 | 152 | 72 | 23.4 | 4.7 | Oct 11, 2024 | J-GAAP |
Sep - Nov, 2024 | 2,440 | 108 | 121 | 111 | 36.2 | 4.4 | Jan 14, 2025 | J-GAAP |
Dec - Feb, 2024 | 2,407 | -21 | -15 | 73 | 23.7 | -0.9 | Apr 14, 2025 | J-GAAP |
YoY | -4.2% | - | - | - | - |
Related Articles
Maruto Sangyo, 15% Increase in Ordinary Profit for The Current Fiscal Year
VALUE CREATION, 50% Increase in Ordinary Profit, Record High for The First Time in Two Years, Dividend Raised by 0.5 yen
Daito Pharma, The Current Fiscal Year Ordinary Profit Revised Downward by 26%
KAWAKAMI PAINT, Dec-Feb (1Q) Ordinary Profit Turns to Loss
AFC-HD AMS Life Science, First Half Ordinary Profit Increases by 26%, Dec-Feb Ordinary Profit Increases by 10%
KAITORI OKOKU, 17% Increase in Ordinary Profit, Record High for The First Time in Two Years
TOKYO KOKI, Last Fiscal Year's Ordinary Profit Exceeds Expectations, 4.7 times Increase in Ordinary Profit for The Current Fiscal Year
TONE, Jun-Feb (Cumulative 3Q) Ordinary Profit Increases by 22%
Takashimaya, 1% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Increased Previous Year's Dividend by 1.5 yen, This Fiscal Year to Increase Dividend
RETAIL PARTNERS, 5% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen